Ross\Johnson & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.59K Buy
22
+2
+10% +$466 0.09% 47
2026
Q1
$4.89K Hold
20
0.09% 50
2025
Q4
$4.14K Hold
20
0.08% 54
2025
Q3
$3.71K Hold
20
0.07% 55
2025
Q2
$3.06K Sell
20
-41
-67% -$6.3K 0.06% 56
2025
Q1
$10.1K Buy
61
+42
+221% +$6.57K 0.17% 52
2024
Q4
$2.75K Buy
+19
New +$2.94K 0.06% 62

Other funds holding JNJ

Ross\Johnson & Associates's JNJ Position: Q2 2026 in Review

Ross\Johnson & Associates increased its Johnson & Johnson (JNJ) stake by 10% in Q2 2026, buying an estimated $466 and bringing the position to 22 shares worth $5.59K. The position accounts for 0.09% of the portfolio, ranked #47.

Ross\Johnson & Associates first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.1K in Q1 2025. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ross\Johnson & Associates held 22 shares of Johnson & Johnson worth $5.59K as of Q2 2026.
  • Ross\Johnson & Associates bought 2 Johnson & Johnson shares in Q2 2026, an estimated $466.
  • Johnson & Johnson made up 0.09% of Ross\Johnson & Associates's portfolio in Q2 2026, its #47 holding.
  • Ross\Johnson & Associates first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's Johnson & Johnson position peaked at $10.1K in Q1 2025.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.